Babylon Health led a series B round for the healthcare measurement kiosk provider that also featured Rush University Medical Center for Health.

Appliance manufacturer Gree bought $89m of shares in an initial public offering in which the oncology therapy developer floated at the top of its range.

WuXi AppTec's Corporate Venture Fund and GV participated in a round that came two years after the drug discovery system developer raised money at a unicorn valuation.

CRUK and Cambridge precision cancer diagnostics spinout Inivata has secured $25m from NeoGenomics as part of a deal that includes an acquisition option.

Cancer diagnostics technology developer Inivata has secured $25m from NeoGenomics to take its total funding to more than $128m.

Roche has purchased Stratos Group's DNA sequencing spinoff five years after its corporate venturing subsidiary contributed to a $30m series B round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Illumina and Amgen-backed genomic sequencing technology developer Oxford Nanopore has added $59.6m to a round that now totals $98.1m.

OCD drug developer Exscientia bagged $60m in a Novo-led round that also featured Bristol-Myers Squibb and existing corporate investor Evotec.

Optum Ventures was among the investors as the mental health management app developer lifted its funding to $145m altogether.